Identifying the prognostic significance of B3GNT3 with PD-L1 expression in lung adenocarcinoma

BACKGROUND: As a novel treatment, programmed cell death protein 1 (PD-1) inhibitor appears to be less effective in tumors of lung adenocarcinoma patients with epidermal growth factor receptor (EGFR) mutation. Beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3) has reported to be associated with prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Leng, Xuefeng, Wei, Shiyou, Mei, Jiandong, Deng, Senyi, Yang, Zhenyu, Liu, Zheng, Guo, Chenglin, Deng, Yulan, Xia, Liang, Cheng, Jiahan, Zhao, Kejia, Gan, Fanyi, Li, Chuan, Merrell, Kenneth W., Molina, Julian R., Metro, Giulio, Liu, Lunxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947420/
https://www.ncbi.nlm.nih.gov/pubmed/33718036
http://dx.doi.org/10.21037/tlcr-21-146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947420/
https://www.ncbi.nlm.nih.gov/pubmed/33718036
http://dx.doi.org/10.21037/tlcr-21-146

Ejemplares similares